Company profile: Interrad Medical
1.1 - Company Overview
Company description
- Provider of innovative medical devices for minimally invasive interventional and surgical procedures, including SecurAcath, a subcutaneous anchoring device that secures peripherally inserted central catheters (PICCs) and other central venous catheters (CVCs), reducing the risk of catheter migration and dislodgement.
Products and services
- Innovative Medical Device Development: Develops innovative medical devices for use in minimally invasive interventional and surgical procedures, supporting minimally invasive-focused applications
- SecurAcath for PICCs: Subcutaneous anchorage-based device that secures peripherally inserted central catheters, reducing risk of catheter migration and dislodgement during use, PICC-specific
- SecurAcath for CVCs: Subcutaneous anchorage-based device securing other central venous catheters, reducing catheter migration and dislodgement risks during use, CVC-compatible
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Interrad Medical
Enchannel
HQ: China
Website
- Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enchannel company profile →
Prevencio
HQ: United States
Website
- Description: Provider of multi-proteomic cardiovascular blood tests: HART CVE uses a machine learning algorithm to predict 1-year risk of heart attack, stroke, or cardiac death; HART CADhs detects obstructive coronary artery disease; HART PAD diagnoses obstructive peripheral artery disease; HART AS diagnoses and monitors aortic valve stenosis (98% exclusion accuracy); HART Amputation Risk assesses amputation risk (87% accuracy).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prevencio company profile →
Fluidx Medical Technology
HQ: United States
Website
- Description: Provider of embolic devices and platforms for targeted vessel occlusion, designed for ease of use and delivery control, including GPX liquid embolic for deep occlusion in oncology and other uses; ULTRA peripheral embolic products with varied occlusion levels for hemorrhage; IMPASS neurovascular embolic for deep, distal penetration and middle meningeal artery embolization; and GPX-Clear with non-artifact radiopacity that dissipates for unobstructed visibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidx Medical Technology company profile →
InterVene
HQ: United States
Website
- Description: Provider of minimally invasive medical devices and therapies for chronic venous disease, particularly deep vein valve failure. The company's BlueLeaf™ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions in the legs, aiming to improve patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InterVene company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Interrad Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Interrad Medical
2.2 - Growth funds investing in similar companies to Interrad Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Interrad Medical
4.2 - Public trading comparable groups for Interrad Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →